Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences is a global medical technology company dedicated to patient-focused innovations for structural heart disease and critical care monitoring. The company is renowned for pioneering artificial heart valves, including advanced transcatheter aortic heart valves (TAVR) such as the Sapien system, and is actively expanding its portfolio in transcatheter mitral and tricuspid therapies (TMTT). Their offerings also encompass comprehensive hemodynamic monitoring solutions, which are crucial for managing critically ill patients.
Driven by a commitment to improving patient outcomes, Edwards Lifesciences collaborates extensively with leading clinicians and researchers to address unmet healthcare needs. A significant and growing area of focus for the company is the integration of artificial intelligence (AI) and machine learning into their products. This includes developing AI-powered algorithms for predictive monitoring in critical care, aiming to assist physicians in making timely, life-critical decisions, predicting adverse outcomes before they occur, and ultimately reducing complications for patients.
Focus Areas
Business Intelligence
| Key Investors | The Vanguard Group, BlackRock, State Street, Wellington Management, J.P. Morgan Asset Management, Jennison Associates, Geode Capital Management (as major institutional shareholders). |
| Partnerships | Philips (for AI-based guide for mitral valve repair with DeviceGuide), Bay Labs (for AI in cardiovascular imaging to improve heart disease detection) |
| Acquisitions | Valtech Cardio (2017), Harpoon Medical (2017), CAS Medical Systems (2019), Innovalve Bio Medical (2024), JenaValve Technology (2024), Endotronix (2024), JC Medical (2024), Vectorious Medical Tech (2023), Corvia Medical (2019), CardiAQ Valve Technologies (2015), BMEYE (2012), Embrella Cardiovascular (2011), Myocor (2008), Percutaneous Valve Technologies (2003). (Note: Edwards' Critical Care business was acquired by BD in 2024). |
| Technology | HemoSphere advanced hemodynamic monitoring platform with Acumen suite (Acumen HPI, Acumen AFM) utilizing machine learning and AI algorithms for predictive decision support and retrospective data analysis. Collaboration with Philips on DeviceGuide AI solution for real-time 3D visualization during mitral valve repair. |
| FDA Clearances | The Acumen suite of intelligent decision-support solutions on the HemoSphere advanced hemodynamic monitoring platform received U.S. FDA clearance in December 2018. The company's Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valve systems were FDA-approved in August 2019. cleared products (estimated) |
What Physicians Need to Know
Edwards Lifesciences stands out for physicians through its commitment to less invasive therapies, offering advanced solutions like TAVR and TMTT that can improve patient outcomes and reduce recovery times. Their deep integration of AI, particularly in predictive hemodynamic monitoring, provides clinicians with crucial, real-time insights to anticipate and proactively manage critical patient conditions, such as hypotension. The company's long-standing collaboration with physicians in research, development, and education ensures that their innovations are clinically relevant and supported by robust evidence. This focus on cutting-edge technology combined with comprehensive clinical support aims to enhance patient safety, optimize care pathways, and ultimately improve the quality of life for individuals with cardiovascular disease.
Edwards Lifesciences has historically focused on making its critical care parameters widely accessible through licensing and integration with various patient monitors, such as Philips IntelliVue. However, it's important to note that BD (Becton, Dickinson and Company) completed the acquisition of Edwards Lifesciences' Critical Care product group in September 2024. This acquisition means that BD now offers these leading monitoring technologies, including advanced AI-enabled clinical decision tools, and aims for future innovation opportunities in closed-loop hemodynamic monitoring and IV fluid/medication administration by integrating combined company data sets and interoperability capabilities. For structural heart therapies and related AI, Edwards continues to develop and integrate its solutions, often through cloud-based platforms like CardioCare, which can incorporate AI algorithms for quality care navigation.
What the Web Says
Edwards Lifesciences generally receives positive to mixed reviews. Product reviews, particularly for their cardiovascular devices, highlight innovation and life-saving capabilities. Employer reviews often praise the company culture, mission-driven work, and benefits, but some employees express concerns about work-life balance and internal bureaucracy.
Overall: MixedStrengths
- Innovative and life-saving medical devices (e.g., TAVR)
- Strong company culture and mission-driven work
- Good benefits and compensation packages
- Opportunities for professional growth and development
- Positive impact on patient lives
- Collaborative work environment
Limitations
- Work-life balance can be challenging due to high demands
- Bureaucracy and slow decision-making in some departments
- Management effectiveness can vary by team
- High-pressure environment in certain roles
- Compensation may not always align with workload for some
- Internal communication issues reported by some employees
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News (general industry sentiment)
Last updated: 2026-07-17
Videos
News, demos, and interviews about Edwards Lifesciences.
Videos load interactively. If none appear, search YouTube for Edwards Lifesciences →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
Tempus AI is a leading health technology company that leverages artificial intelligence (AI) and machine learning to advance precision medicine. Founded in 2015 by Eric Lefkofsky, the company was inspired by the need for more data-driven approaches in oncology care. Tempus has since built one of the world’s largest libraries of multimodal clinical and molecular […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]
SureMediks, a product of Rasimo Systems, LLC, is an AI-powered Clinical Operating System designed for longitudinal care, aiming to transform episodic healthcare into continuous, intelligent, and personalized patient management. The platform integrates patients, healthcare providers, clinical protocols, AI, connected medical devices, and electronic medical records into a unified ecosystem. SureMediks processes continuous real-world patient data […]
SOAP Health is a healthcare AI company focused on improving early disease detection and diagnosis at the point of care. The company’s mission is to save lives by augmenting physicians’ capabilities to perform in-depth risk and symptom assessments. They aim to achieve this by leveraging conversational and generative AI to enhance patient intake, streamline risk […]